PMID- 14597592 OWN - NLM STAT- MEDLINE DCOM- 20031208 LR - 20161124 IS - 1524-4539 (Electronic) IS - 0009-7322 (Linking) VI - 108 IP - 19 DP - 2003 Nov 11 TI - Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. PG - 2368-76 AB - BACKGROUND: Stratification of pediatric patients with congenital heart disease (CHD) has been based on their hemodynamics and/or functional capacity. Our purpose was to compare cardiac autonomic nervous activity (CANA) and neurohormonal activities (NHA) with postoperative status in stable CHD patients with biventricular physiology. METHODS AND RESULTS: We divided 379 subjects (297 CHD patients, 28 dilated cardiomyopathy patient, and 54 control subjects) into 4 subgroups according to New York Heart Association (NYHA) class (1.3+/-0.7) and measured various CANA and NHA indices. Stepwise decreases in baroreflex sensitivity (BRS), heart rate variability (HRV), adrenergic imaging, and vital capacity (VC) were observed in proportion to functional capacity in normal to NYHA II patients (P<0.001). However, there were no differences in these indices between NYHA II and III+IV groups, whereas a stepwise proportional increase in NHA indices was observed in these groups (P<0.001). Natriuretic peptides differentiated all NYHA classes. BRS, HRV, and VC were greater in the adult patients than in the child patients (P<0.05 to 0.01), although the functional class in adult patients was lower. Cardiac surgeries resulted in low BRS and VC, and the VC reduction independently determined a small HRV. Even if functional class and ejection fraction were comparable, CANA and brain natriuretic peptide were lower in CHD patients than in dilated cardiomyopathy patients (P<0.05 to 0.001). CONCLUSIONS: CANA and NHA indices are useful to stratify mild and severe heart failure in stable postoperative CHD patients, respectively. However, careful attention should be paid to age- and surgery-related influences on these indices. FAU - Ohuchi, Hideo AU - Ohuchi H AD - Department of Pediatrics, National Cardiovascular Center, 5-7-1, Fujishiro-dai, Suita, Osaka 565-8565, Japan. hohuchi@hsp.ncvc.go.jp FAU - Takasugi, Hisashi AU - Takasugi H FAU - Ohashi, Hiroyuki AU - Ohashi H FAU - Okada, Yoko AU - Okada Y FAU - Yamada, Osamu AU - Yamada O FAU - Ono, Yasuo AU - Ono Y FAU - Yagihara, Toshikatsu AU - Yagihara T FAU - Echigo, Shigeyuki AU - Echigo S LA - eng PT - Comparative Study PT - Journal Article DEP - 20031103 PL - United States TA - Circulation JT - Circulation JID - 0147763 RN - 114471-18-0 (Natriuretic Peptide, Brain) RN - 85637-73-6 (Atrial Natriuretic Factor) RN - EC 3.4.23.15 (Renin) RN - YKH834O4BH (Epinephrine) SB - IM MH - Adolescent MH - Adult MH - Atrial Natriuretic Factor/blood MH - Baroreflex/physiology MH - Cardiomyopathy, Dilated/blood/etiology/physiopathology MH - Child MH - Child, Preschool MH - Epinephrine/blood MH - Forced Expiratory Volume MH - Heart/diagnostic imaging MH - Heart Defects, Congenital/*complications/surgery MH - Heart Failure/blood/*classification/etiology/physiopathology MH - Hemodynamics MH - Humans MH - Infant MH - Natriuretic Peptide, Brain/blood MH - Postoperative Complications/blood/physiopathology MH - Prospective Studies MH - Radionuclide Imaging MH - Reflex, Abnormal MH - Renin/blood MH - Severity of Illness Index MH - Vital Capacity EDAT- 2003/11/05 05:00 MHDA- 2003/12/10 05:00 CRDT- 2003/11/05 05:00 PHST- 2003/11/05 05:00 [pubmed] PHST- 2003/12/10 05:00 [medline] PHST- 2003/11/05 05:00 [entrez] AID - 01.CIR.0000101681.27911.FA [pii] AID - 10.1161/01.CIR.0000101681.27911.FA [doi] PST - ppublish SO - Circulation. 2003 Nov 11;108(19):2368-76. doi: 10.1161/01.CIR.0000101681.27911.FA. Epub 2003 Nov 3.